United States: Baxalta's Antibody Patent Held Invalid Under Amgen's Enablement Standard By The Federal Circuit - Haug Partners

In Baxalta, Inc. v. Genentech, Inc., the Court of Appeals for the Federal Circuit upheld a summary judgment finding from the District of Delaware (Judge Timothy B. Dyk) that claims 1-4, 19 and 20...